Allison Hulme's Net Worth

$0

Estimate Recalculated Sep 9, 2024 03:49PM EST

Who is Allison Hulme?

Allison Hulme does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SOPHIRIS BIO INC., and Ventyx Biosciences, Inc..

SEC CIK

Allison Hulme's CIK is 0001573886

Past Insider Trading and Trends

2023 was Allison Hulme's most active year for acquiring shares with 3 total transactions. Allison Hulme's most active month to acquire stocks was the month of November. 2013 saw Allison Hulme paying a total of $0.00 for 609,016 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SOPHIRIS BIO INC. No price found

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
Dec 7
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Feb 5
Form 4/A
—
0
—
—
0
Oct 25
Form 4
—
0
—
—
0
Oct 25
Form 3
—
0
—
—
0
No matching records found

Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jun 15
Form 4/A
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
Jan 11
Form 3
—
0
—
—
0
No matching records found